Close Menu

cell analysis

Livecyte enables users to automatically characterize growth, morphology, and motility of large populations of cells in 96-well plates.

The joint venture will further develop, manufacture, and distribute LevitasBio's magnetic levitation-based cell separation and purification platform in China. 

Evorion also closed a financing round for an undisclosed amount, and Jüke has become a shareholder in the company.

In its first complete quarter as a publicly traded company, Berkeley Lights reported $18.2 million in total revenues, including $4.1 million in service revenues.

The newly public company has attracted attention from both investors and competitors for its technology platform used in antibody discovery workflows.

An international team of researchers put nine immune cell sequencing methods head to head, including RNA-based and DNA-based ones, using the same T-cell sample.

The cell analysis firm, which went public in July, saw service revenues fall 63 percent, offset by 17 percent growth in product revenues.

Wall Street analysts are bullish on the firm's cell selection platform technology, which could find a total addressable market of more than $20 billion.

The Emeryville, California-based instrument maker expects to raise $178.2 million after offering 8.1 million shares at $22 per share.

By screening more than 1,500 drugs against patient-derived glioblastoma cells, researchers tracked down tumor alterations with apparent ties to proteasome inhibitor response.

Pages

The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.

According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.

The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.

In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.